Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals RSUs — Shares granted in period (M shares) by Year
RSUs — Shares granted in period (M shares) (M)
Vertex Pharmaceuticals RSUs — Shares granted in period (M shares): 1.47M in FY2025, up 6.5% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Stock-based Compensation — RSU Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | RSUs — Shares granted in period (M shares) (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.47 | +6.5% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 1.38 | -12.1% | Form 10-K (filed 2025-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 1.57 | -8.2% | Form 10-K (filed 2024-02-15) ↗ |
| FY2022 | Dec 31, 2022 | 1.71 | -11.4% | Form 10-K (filed 2023-02-10) ↗ |
| FY2021 | Dec 31, 2021 | 1.93 | +55.6% | Form 10-K (filed 2022-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 1.24 | -27.9% | Form 10-K (filed 2021-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 1.72 | +7.5% | Form 10-K (filed 2020-02-13) ↗ |
| FY2018 | Dec 31, 2018 | 1.60 | -7.0% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 1.72 | +102.4% | Form 10-K (filed 2018-02-15) ↗ |
| FY2016 | Dec 31, 2016 | 0.85 | +750.0% | Form 10-K (filed 2017-02-23) ↗ |
| FY2015 | Dec 31, 2015 | 0.10 | – | Form 10-K (filed 2016-02-16) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals RSUs — Shares granted in period (M shares) (M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rsu-granted-sh
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.